The Oncology Institute Warrant
TOIIW
TOIIW was delisted on the 31st of July, 2026.
13 hedge funds and large institutions have $2.77M invested in The Oncology Institute Warrant in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
8% more funds holding
Funds holding: 12 → 13 (+1)
0.81% more ownership
Funds ownership: 4.79% → 5.6% (+0.81%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
62% less capital invested
Capital invested by funds: $7.36M → $2.77M (-$4.59M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
+$116K |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
+$85.8K |
| 3 |
CAC
Cowen and Company
New York
|
+$39.2K |
| 4 |
JFG
Jefferies Financial Group
New York
|
+$31K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
USPCM
Union Square Park Capital Management
New York
|
-$66K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$3.28K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.59K |
TOIIW Hedge Fund Activity: Q4 2022 in Review
13 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute Warrant (TOIIW) for Q4 2022, worth a combined $2.77M — down 62% from $7.36M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new TOIIW positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Walleye Capital, opening a new position worth an estimated $116K. The largest seller was Union Square Park Capital Management, exiting entirely with an estimated $66K sold.
- 13 institutional investors held The Oncology Institute Warrant (TOIIW) as of Q4 2022, up from 12 in Q3 2022.
- Funds reported $2.77M of The Oncology Institute Warrant stock for Q4 2022, down 62% quarter-over-quarter.
- 3 funds opened new The Oncology Institute Warrant positions in Q4 2022 and 1 closed out, a net change of +2 holders.
- The largest The Oncology Institute Warrant buyer in Q4 2022 was Walleye Capital, an estimated $116K added.
- The largest The Oncology Institute Warrant seller in Q4 2022 was Union Square Park Capital Management, an estimated $66K sold.
Based on aggregated 13F filings for Q4 2022.